Stepped care for depression and anxiety: From primary care to specialized mental health care: A randomised controlled trial testing the effectiveness of a stepped care program among primary care patients with mood or anxiety disorders

BMC Health Services Research

Volumn 9, Issue , 2009, Pages

  Seekles, Wike ^a,b   Van Straten, Annemieke ^a,b   Beekman, Aartjan ^b   Van Marwijk, Harm ^b   Cuijpers, Pim ^a,b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGORAPHOBIA; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DYSTHYMIA; GENERAL PRACTITIONER; GENERALIZED ANXIETY DISORDER; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; MAJOR DEPRESSION; MENTAL HEALTH CARE; MOOD DISORDER; PANIC; PATIENT MONITORING; PRIMARY MEDICAL CARE; PROBLEM SOLVING; RANDOMIZED CONTROLLED TRIAL; SCREENING; SELF HELP; SOCIAL PHOBIA; WATCHFUL WAITING; ADOLESCENT; ANXIETY; DEPRESSION; EVIDENCE BASED MEDICINE; FEMALE; HEALTH SERVICES RESEARCH; MALE; MENTAL HEALTH SERVICE; METHODOLOGY; MIDDLE AGED; NETHERLANDS; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PRIMARY HEALTH CARE; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANXIETY; CONTINUITY OF PATIENT CARE; DEPRESSION; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; NETHERLANDS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; RESEARCH DESIGN;

EID: 67651171663     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-9-90     Document Type: Article

References (76)

1. Psychiatrische morbiditeit onder volwassenen in Nederland: het NEMISIS-onderzoek. II. Prevalentie van psychiatrische stoornissen. RV Bijl G van Zessen A Ravelli, Nederlands Tijdschrift voor Geneeskunde 1997 141 2453 60 9555131
2. Projections of global mortality and burden of disease from 2002 to 2030. CD Mathers D Loncar, PLoS Med 2006 3 e442 17132052 10.1371/journal.pmed.0030442 (Pubitemid 44875937)
3. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. KB Wells A Stewart RD Hayes MA Burnam W Rogers M Daniels S Berry S Greenfield J Ware, Jama 1989 262 914 919 2754791 10.1001/jama.262.7. 914 (Pubitemid 19208948)
4. Disability and depression among high utilizers of health care: a longitudinal analysis. M Von Korff J Ormel W Katon EHB Lin, Archives of general psychiatry 1992 2 91 100
5. Care utilization and outcome of DSM-III-R major depression in the general population. Results from The Netherlands Mental Health Survey and Incidence Study (NEMISIS). J Spijker RV Bijl R de Graaf WA Nolen, Acta Psychiatr Scand 2001 104 19 24 10.1034/j.1600-0447.2001.00363.x 11437745 (Pubitemid 32532325)
6. Economic costs of minor depression: a population-based study. P Cuijpers F Smit J Oostenbrink R de Graaf M Ten Have A Beekman, Acta Psychiatr Scand 2007 115 229 236 10.1111/j.1600-0447.2006.00851.x 17302623 (Pubitemid 46246267)
7. The Epidemiology of Major Depressive Disorder: Results from the National Comorbidity Survey Replication (NCS-R). RC Kessler P Berglund O Demler R Jin D Koretz RK Merikangas AJ Rush EE Walters PS Wang, Jama 2003 289 3095 3105 10.1001/jama.289.23.3095 12813115 (Pubitemid 37432885)
8. Are psychological and pharmacological interventions equally effective in the treatment of adult depressive disorder? P Cuijpers A van Straten P van Oppen G Andersson, J clin psychiatry 2008 69 1675 1685 18945396
9. Collaborative Paroxetine Investigators. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Y Lecrubier A Bakker R Judge, Acta Psychiatr Scand 1997 95 145 152 10.1111/j.1600-0447.1997. tb00388.x 9065680
10. Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study. J Bradwejn A Ahokas DJ Stein E Salinas G Emilien T Whitaker, The British Journal Of Psychiatry: The Journal Of Mental Science 2005 187 352 9 10.1192/bjp.187.4.352 16199795 (Pubitemid 41442388)
11. A metaanalysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments. AJLM Balkom A van Bakker Ph Spinhoven BMJW Blaauw S Smeenk B Ruesink, The Journal of Nervous and Mental Disease 1997 185 510 517 10.1097/00005053-199708000-00006 (Pubitemid 27376660)
12. Antidepressants for generalized anxiety disorder. F Kapczinski MS Lima JS Souza A Cunha R Schmitt, Cochrane Database of Systematic Reviews 2003 2 CD003592
13. Psychological therapies for generalised anxiety disorder. V Hunot R Churchill V Teixeira M Silva de Lima, Cochrane Database of Systematic Reviews 2007 1 CD001848
14. One-session treatment for specific phobias. LG st, Behav Res Ther 1989 27 1 7 10.1016/0005-7967(89)90113-7 2914000 (Pubitemid 19012154)
15. Double-blind placebo-cotrolled pilot study of paroxetine for specific phobia. J Benjamin IZ Ben-Zion E Karbofsky P Dannon, Psychopharmacology (Berlin) 2000 149 194 196 10.1007/s002130000372
16. Randomised controlled trails in psychiatry. G Andrews, BMJ 1999 319 7209 562 564 10463902
17. Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. G Andrews C Issakidis K Sanderson J Corry H Lapsley, British Journal of Psychiatry 2004 184 526 533 10.1192/bjp.184.6.526 15172947 (Pubitemid 38725713)
18. Implementation of Guideline-Based Care for Depression in Primary Care. BL Rollman L Weinreb N Korsen HC Schulberg, Adm Policy Ment Health 2006 33 43 53 10.1007/s10488-005-4235-1 16215662 (Pubitemid 43305629)
19. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. PS Wang S Aguilar-Gaxiola J Alonso MC Angermeyer G Borges EJ Bromet R Bruffaerts, Lancet 2007 370 841 50 10.1016/S0140-6736(07)61414-7 17826169 (Pubitemid 47362343)
20. Doelmatig voorschrijven van antidepressiva in de huisartspraktijk. A Volkers A de Jong D de Bakker L van Dijk, Utrecht: NIVEL 2005
21. Tweede nationale study naar ziekten en verrrichtingen in de huisartspraktijk. Huisartsenzorg: wat doet de poortwachter? M Cardol L van Dijk JD de Jong DH de Bakker GP Westert, Utrecht/Bilthoven: NIVEL/RIVM 2004
22. Applicability of Clinical Pharmacotherapy Guidelines for Major Depression in Primary Care Settings. HC Schulberg MR Block MJ Madonia, Arch Fam Med 1995 4 106 112 10.1001/archfami.4.2.106 7842147
23. The 'Usual Care' of Major Depression in Primary Care Practice. HC Schulberg MR Block MJ Madonia, Arch Fam Med 1997 6 334 339 10.1001/archfami.6.4. 334 9225703
24. Patterns of antidepressant use in community practice. G Simon M Von Korff EH Wagner W Barlow, Gen Hosp Psychiatry 1993 15 399 408 10.1016/0163-8343(93) 90009-D 8112564 (Pubitemid 24006273)
25. Patients' preferences in the treatment of depressive disorder in primary care. DJ Van Schaik AF Klijn HP Van Hout HW Van Marwijk AT Beekman M De Haan R van Dyck, Gen Hosp Psychiatry 2004 26 184 189 10.1016/j.genhosppsych.2003.12.001 15121346 (Pubitemid 38581923)
26. Collaborative Management to Achieve Treatment Guidelines. Impact on Depression in Primary Care. W Katon M Von Korff E Lin E Walker GE Simon T Bush P Robinson J Russo, Jama 1995 273 1026 1031 7897786 10.1001/jama.273.13.1026
27. Stepped care in psychological therapies: access, effectiveness and efficiency. Narrative literature review. P Bower S Gilbody, British Journal of Psychiatry 2005 186 11 17 10.1192/bjp.186.1.11 15630118 (Pubitemid 40070538)
28. Minder is meer. Stepped care in de geestelijke gezondheidszorg [Less is more. Stepped Care in mental health care]. JAC Meeuwissen MCH Donker, Maandblad Geestelijke volksgezondheid 2004 59 904 915
29. Stepped care vs. Matched care for mood and anxiety disorders: a randomized trail in routine practice. A Van Straten B Tiemens L Hakkaart WA Nolen MCH Donker, Acta Psychiatr Scand 2006 113 468 476 10.1111/j.1600-0447. 2005.00731.x 16677223 (Pubitemid 43748602)
30. Treating depression in primary care in low-income woman in Santiago, Chile: a randomised controlled trial. R Araya G Rojas R Fritsch J Gaete, The Lancet 2003 361 995 1000 10.1016/S0140-6736(03)12825-5 (Pubitemid 36351367)
31. The hospital anxiety and depression scale. AS Zigmond RP Snaith, Acta Psychiatr Scand 1983 67 361 370 10.1111/j.1600-0447.1983.tb09716.x 6880820
32. The Alcohol Use Disorder Identification Test: Guidelines for Use in Primary Health Care. TF Babor JR de la Fuente J Saunders M Grant, Geneva: World Health Organisation 1989
33. Composite International Diagnostic Interview (CIDI). World Health Organisation, Geneva: WHO 1990
34. Duration of major depressive episodes in the general population: Results from The Netherlands Mental Health Survey and Incidence Study (NEMISIS). J Spijker R de Graaf RV Bijl AT Beekman J Ormel WA Nolen, The British Journal of psychiatry 2002 181 208 213 10.1192/bjp.181.3.208 12204924 (Pubitemid 34983527)
35. Randomised controlled trail of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. LM Mynors-Wallis DH Gath A Day F Baker, BMJ 2000 320 26 30 10617523 10.1136/bmj.320.7226.26
36. LM Mynors-Wallis, Problem Solving Treatment for anxiety and depression: A practical guide Oxford: University Press 2005
37. Evalutation of a brief psychological treatment for emotional disorders in primary care. J Catalan DH Gath A Bond A Day L Hall, Psychol Med 1991 21 1013 1018 1780394
38. Randomised controlled trial comparing problem-solving treatment with amitriptyline and placebo for major depression in primary care. LM Mynors-Wallis DH Gath AR Lloyd-Thomas D Tomlinson, BMJ 1995 310 441 445 7873952
39. Problem-solving treatment: evidence for effectiveness and feasibility in primary care. LM Mynors-Wallis, Int J Psychiatry Med 1996 26 249 262 10.2190/0HVY-CD2F-0KC7-FVTB 8976466
40. A randomized controlled trail and cost analysis of problem-solving treatment for emotional disorders given by community nurses in primary care. LM Mynors-Wallis I Davies A Gray F Barbour D Gath, Br J Psychiatry 1997 170 113 119 10.1192/bjp.170.2.113 9093498
41. Training therapists in problem-solving treatment of depressive disorders in primary care: lessons learned from the Treatment Effectiveness Project. M Hegel J Barrett T Oxman, Fam Syst Health 2000 18 423 435
42. Treatment of dyshymia and major depression in primary care: a randomised trial in patients aged 18-65. JE Barrett JW Williams TE Oxman E Frank W Katon M Sullivan MT Hegel JE Cornell AS Sengupta, The Journal of Family Practice 2001 50 405 412 11350703
43. Behavioural Psychotherapy. I Marks, Bristol: Jon Wright [now published by I. Marks, Institute of Psychiatry, London.] 1986
44. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), Clinician Rating (QIDS-C), and Self-Report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. JA Rush MH Trivedi HM Ibrahim TJ Carmody B Arnow DN Klein JC Markowitz PT Ninan S Kornstein R Manber ME Thase JH Kocsis MB Keller, Society of Biological Psychiatry 2003 54 573 583 10.1016/S0006-3223(02)01866-8 (Pubitemid 37289444)
45. HADS: Hospital Anxiety and Depression Scale. RP Snaith AS Zigmond, Windsor: NFER Nelson 1994
46. The link between depression and physical symptoms. MH Trivedi, Prim Care Companion J Clin Psychiatry 2004 6 Suppl 1 12 16 16001092
47. Effects of age on symptoms of anxiety and depression in a sample of retired police officers. A Tuohy C Knussen MJ Wrennall, Psychology and aging 2005 2 202 210 10.1037/0882-7974.20.2.202 (Pubitemid 41023400)
48. Drie vragenlijsten voor diagnostiek van depressie en angststoornissen. EM De Croon K Nieuwenhuijsen NIR Hugenholtz FJH Van Dijk, TBV 13 2005 4 98 103
49. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. RC Kessler G Andrews LJ Colpe E Hiripi DK Mroczek SL Normand, Psychological Medicine 2002 32 959 976 10.1017/ S0033291702006074 12214795 (Pubitemid 34928288)
50. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). RC Kessler P Berglund O Demler R Jin D Koretz KR Merikangas, Journal of the American Medical Association 2002 289 3095 3105 10.1001/jama.289.23.3095
51. Factor Structure and Interpretation of the K10. RT Brooks J Beard Z Steel, Psychological Assessment 2006 18 62 70 10.1037/1040-3590.18.1.62 16594813 (Pubitemid 43824262)
52. The validity of the extended K10 screening scale for depressive and anxiety disorders. T Donker HC Comijs P Cuijpers B Terluin WA Nolen FG Zitman BW Penninx, Psychiatry Research
53. Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV) - Text Revision. American Psychiatric Association, Washington 2001
54. Validation of two survey diagnostic interviews among primary care attendees: A Comparison of CIS-R and CIDI with SCAN ICD-10 diagnostic categories. V Jordanova C Wickramesinghe C Gerarda M Prince, Psycological Medicine 2004 36 1013 1024 10.1017/S0033291703001727 (Pubitemid 39199971)
55. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. PH Spinhoven J Ormel PPA Sloekers GIJM Kempen AEM Speckens AM van Hemert, Psychological Medicine 1997 27 363 370 10.1017/S0033291796004382 9089829 (Pubitemid 27139969)
56. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. JC Mundt IM Marks MK Shear JH Greist, British Journal of Psychiatry 2002 180 461 464 10.1192/bjp.180.5.461 11983645 (Pubitemid 34499343)
57. Het meten van de algemene gezondheidstoestand met de MOS Short-Form General Health Survey (SF-20): een handleiding. GIJM Kempen EI Brilman JW Heyink, Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken, Rijksuniversiteit Groningen 1995
58. The MOS Short-form General Health Survey - reliability and validity in a patient population. AL Stewart RD Hays JE Ware, Medical Care 1988 26 724 735 10.1097/00005650-198807000-00007 3393032
59. EuroQoL: the current state of play. R Brooks, Health Policy 1996 37 53 72 10.1016/0168-8510(96)00822-6 10158943 (Pubitemid 26191458)
60. Kwaliteit van leven meten in economische evaluaties: Het Nederlands EQ-5D-tarief. LM Lamers PFM Stalmeier J McDonnell PFM Krabbe JJ van Busschbach, Ned Tijdschr Geneeskd 2005 149 1574 8 16038162
61. The Four-Dimensional Symptom Questionnaire (4DSQ): a validation study of a multidimensional self-report questionnaire to assess distress, depression, anxiety and somatization. B Terluin HWJ van Marwijk HJ Adèr HCW de Vet BWJH Penninx MLM Hermens CA van Boeijen AJLM van Balkom JJL van der Klink WAB Stalman, BMC Psychiatry 2006 6 34 16925825 10.1186/1471-244X-6-34 (Pubitemid 44523855)
62. Use of the AUDIT and the DAST-10 to identify Alcohol and Drug Use Disorders among adults with a severe and persistent mental illness. SA Maisto MP Carey KB Carey CM Gordon JR Gleason, Psychological Assessment 2000 12 186 192 10.1037/1040-3590.12.2.186 10887764
63. The AUDIT questionnaire: choosing a cut-off score. Alcohol Use Disorder Identification Test. KM Conigrave WD Hall JB Saunders, Addiction 1995 90 1349 1356 10.1111/j.1360-0443.1995.tb03552.x 8616463
64. A review of research on the Alcohol Use Disorders Identification Test (AUDIT). JP Allen RZ Litten JB Fertig T Barbor, Alcohol Clin Exp Res 1997 21 613 619 9194913
65. Personality in adulthood: A six-year longitudinal study of self-reports and spouse ratings on the NEO Personality Inventory. PT Costa RR McCrae, Journal of Personality and Social Psychology 1988 54 853 863 10.1037/0022-3514.54.5.853
66. Neuroticism as a common feature of the depressive and anxiety disorders: a test of the revised integrative hierarchical model in a national sample. LM Weinstock MA Whisman, J Abnorm Psychol 2006 115 68 74 10.1037/0021-843X.115.1.68 16492097 (Pubitemid 43306366)
67. Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI) professional manual. PT Costa Jr RR McCrae, Odessa, FL: Psychological Assessment Resources 1992
68. L Hakkaart-van Roijen, Manual Trimos/iMTA questionaire for costs associated with psychiatric illness (in Dutch) Rotterdam: Institute for Medical Technology Assessment 2002
69. Quality of care from the patients' perspective: From theoretical a concept to a new measuring instrument. HJ Sixma JJ Kerssens C Campen L van Peters, Health Expect 1998 1 82 95 10.1046/j.1369-6513.1998.00004.x 11281863
70. The Structure of coping. LI Pearlin C Schooler, J Health Soc Behav 1978 19 2 21 10.2307/2136319 649936
71. J Cohen, Statistical Power Analysis for the Behavioral Sciences Hillsdale, New Jersey: Erlbaum 2 1988
72. Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide. J Twisk, Cambridge Universitey Press 2003
73. Pragmatic controlled clinical trails in primary care: the struggle between external and internal validity. M Godwin L Ruhland I Casson S MacDonald D Delva R Birtwhistle M Lam R Seguin, BMC Medical Research Methodology 2003 3 28 14690550 10.1186/1471-2288-3-28
74. Rethinking practitioner roles on chronic illness: the specialist, primary care physician, and the practice nurse. W Katon M Von Korrf E Lin G Simon, Gen Hosp Psychiatry 2001 23 138 144 10.1016/S0163-8343(01)00136-0 11427246 (Pubitemid 32586816)
75. Costs and consequences of enhanced primary care for depression: Systematic review of randomised economic evaluations. S Gilbody P Bower P Whitty, British Journal of Psychiatry 2006 189 297 308 10.1192/bjp.bp.105.016006 17012652 (Pubitemid 44606742)
76. Cost-utility of brief psychological treatment for depression and anxiety. L Hakkaart-van Roijen A Van Straten M Al F Rutten M Donker, Br J Psychiatry 2006 188 323 329 10.1192/bjp.188.4.323 16582058